Trademarkia Logo

Canada

C$
SKYCLARYS
REGISTERED

on 5 Feb 2024

Last Applicant/ Owned by

Reata Pharmaceuticals, Inc.

2801 Gateway Drive, Suite 150Irving TX 75063

US

Serial Number

2034714 filed on 3rd Mar 2020

Registration Number

TMA1220216 registered on 5th Feb 2024

Registration expiry Date

3rd Mar 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

SKYCLARYS

Trademark usage description

pharmaceutical preparations for the prevention and treatment of disorders of the central and peripheral nervous systems, the cardiovascular system, th Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of disorders of the central and peripheral nervous systems, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases, diseases, and disorders of the immune system including autoimmune diseases, skin diseases, and kidney diseases.


Classification kind code

11

Mark Details


Serial Number

2034714

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 7th Oct 2021
Search Recorded
Submitted for opposition 20
on 7th Oct 2021
Examiner's First Report
Submitted for opposition 223
on 7th Oct 2021
Total Provisional Refusal
Submitted for opposition 256
on 19th Apr 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 27th Jul 2020
Agent Changed
Submitted for opposition 257
on 18th Jun 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 17th Jun 2020
Created
Submitted for opposition 31
on 17th Jun 2020
Formalized
Submitted for opposition 228
on 3rd Mar 2020
International Registration
Submitted for opposition 30
on 3rd Mar 2020
Filed